Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

2,625.00p
   
  • Change Today:
    -40.00p
  • 52 Week High: 4,500.00
  • 52 Week Low: 2,350.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 1,922
  • Market Cap: £137.15m
  • Beta: 0.01

Latest Deals

Traded Action Notifier PriceAmountValue
28-Apr-25 Buy Bruce Hiscock 2,632.00p 31 £815.92
23-Dec-24 Buy Bruce Hiscock 273.00p 61 £166.53
22-Nov-24 Buy Bruce Hiscock 3,822.00p 24 £917.28
30-Oct-24 Buy Bruce Hiscock 3,330.00p 300 £9,990.00

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
30-Oct-24 Buy Bruce Hiscock 3,330.00p 300 £9,990.00
22-Nov-24 Buy Bruce Hiscock 3,822.00p 24 £917.28
28-Apr-25 Buy Bruce Hiscock 2,632.00p 31 £815.92
23-Dec-24 Buy Bruce Hiscock 273.00p 61 £166.53

Director Shareholdings

Notifier Holding Value*
Peter John Harrison 297,088 £7,798,560
Ian James Nicholson 13,000 £341,250
Bruce Hiscock 1,236 £32,445

Major Shareholders

Notifier** Holding Value*
Rathbones Investment Management Ltd 5,219,656 £137,015,970
Castlefield Fund Partners Limited 985,000 £25,856,250
SANFORD DELAND ASSET MANAGEMENT LTD 885,000 £23,231,250
Gresham House Asset Management Limited 627,782 £16,479,278
SANFORD DELAND ASSET MANAGEMENT LTD 619,500 £16,261,875
Miton Group plc 508,135 £13,338,544
The Diverse Income Trust plc 302,300 £7,935,375
Schroders plc 284,795 £7,475,869
Wasatch Advisors, Inc. 265,000 £6,956,250
Canaccord Genuity Group Inc 259,940 £6,823,425
Adrian Williams 253,372 £6,651,015

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 2,625.00p
Change Today -40.00p
% Change -1.50 %
52 Week High 4,500.00
52 Week Low 2,350.00
Volume 1,922
Shares Issued 5.22m
Market Cap £137.15m
Beta 0.01

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
0.72% above the market average0.72% above the market average0.72% above the market average0.72% above the market average0.72% above the market average
90.70% above the sector average90.70% above the sector average90.70% above the sector average90.70% above the sector average90.70% above the sector average
Price Trend
72.78% below the market average72.78% below the market average72.78% below the market average72.78% below the market average72.78% below the market average
42.22% above the sector average42.22% above the sector average42.22% above the sector average42.22% above the sector average42.22% above the sector average
Income
54.17% above the market average54.17% above the market average54.17% above the market average54.17% above the market average54.17% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Growth
6.3% below the market average6.3% below the market average6.3% below the market average6.3% below the market average6.3% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 10-Apr-25 07-Nov-24
Paid 25-Apr-25 21-Nov-24
Amount 70.00p 87.00p

Trades for 04-Aug-2025

Time Volume / Share Price
16:08 137 @ 2,600.00p
14:48 0 @ 2,650.00p
14:48 0 @ 2,650.00p
14:48 14 @ 2,600.00p
14:37 280 @ 2,600.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page